All In MedTech

Device Trial Radar · NCT06690333

Efficacy and Safety of Leadless Pacemakers Versus Left Bundle Area Pacing - A Preliminary Exploration

Last checked: Nov 20, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

75

Planned (sponsor's estimate)

Start

Nov 5, 2024

Primary completion

Dec 2026

Study completion Dec 2026

Sponsor

Sponsor type
Academic, hospital or other
Collaborators
Medtronic
First posted
Nov 15, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective, randomized controlled (1:1) multicenter trial. The pilot study will be conducted up to three clinical sites in the United States. The primary purpose of this study is to compare the overall safety and efficacy between the leadless pacemaker and left bundle area pacing.

Conditions

  • Pacemaker Implantation
  • AV Node Disease

Interventions

  • PacemakerDevice

    Transvenous pacemaker with left bundle area pacing

  • PacemakerDevice

    Transcatheter pacemaker with MICRA AV

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy & SafetyTime frame: 12 months

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • NCH Healthcare

    Naples, Florida · Recruiting

  • Massachusetts General Hospital

    Boston, Massachusetts · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.